T0	Participants 17 72	salbutamol-treated inpatients with acute bronchiolitis:
T1	Participants 175 262	children admitted to the hospital with bronchiolitis treated with nebulized salbutamol.
T2	Participants 388 646	participants, children aged 6 weeks to 15 months, admitted with first-time wheezing, were eligible if their oxygen saturation was less than 95% on admission to the hospital and their Respiratory Distress Assessment Instrument (RDAI) score was greater than 6.
T3	Participants 647 876	Patients were excluded if they had any one of the following: an underlying disease that might affect cardiopulmonary status, asthma, recent treatment with steroids (within 2 weeks), or any history of adverse reaction to steroids.
T4	Participants 2029 2069	children hospitalized with bronchiolitis